Trial Details
WITHDRAWNBasic Information
| Clinical ID | c3854 |
|---|---|
| Identifier | NCT01433432 |
| Trial Title | Open Label Extension Study to Protocol C2/13/DR-6MP-02 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: 80 mg DR-6MP |
Participant Information
| Sponsor | Teva GTC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2011-10 |
|---|---|
| Primary Completion Date | 2012-06 |
| Completion Date | 2012-08 |